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3. Conclusion:
Recent advances in mapping and ablation of
focal tachycardia provide a safe and successful
curative therapy. However, recognition of such
tachycardia is the key factor for successful manage-
ment. A standard 12-lead surface ECG provides a
simple and non-invasive method that can help in
determining the origin of tachycardia.
Figure 1. Pre-ablation twelve leads electrocardio-
gram showed left atrial tachycardia, rate of
160 beats/min, note the inverted P wave at lead I,
aVL, and upright P-waves at inferior leads and V1.
Figure 2. Three dimensional left atrial geometry
by non-contact mapping system (NAV-X-Endocar-
dial Solutions, Inc. (ESI), St. Paul, Minnesota)
showed the atrial tachycardia focus adjacent to
the left superior pulmonary vein.
Figure 3. Post ablation twelve leads electrocardio-
gram showed sinus tachycardia rate of 120 beat/min.
Note the normalization of the P-wave axis.
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Drug eluted balloon has the potential to treat in-
stent restenosis and small vessels disease
M. Balghith, A. Alghamdi, K. Ayoub, B. Saeed
Background: In-stent restenosis still a major prob-
lem after percutanous coronary intervention. One-quar-
ter of DESs can result in restenosis, paclitaxel-coated
coronary balloons showed an advantage in patients with
in-stent restenosis in different clinical studies, small ves-
sels disease is a challenge in coronary intervention
Methods: Single center study in our cath lab
between Jan 2010–Oct 2011, a total of 36 patients, with
either in-stent restenosis more than 50%, or small vessel
disease, under went balloon angioplasty using a Dior
Eurocor, Drug Eluted Balloon to treat those lesions.
And patients were prepared in the same way of regular
PCI, given heparin and clopidogrel loading and mainte-
nance dose accordingly. We are planning to f/u the
patients clinically for 6 months to 2 years.
Results: Total of 36 patients, 10 (28%) patients had
in-stent restenosis treated by DEB. 26 (72%) patients
had a small vessels disease, diameter <2.5 mm treated
with DEB and balloon size range from 2.0 to 2.25 mm.
The incidence of diabetes mellitus was 70%. Hyperten-
sion 67%. Majority of patients are male patients (26).
The disease was involving all vessels including RCA,
PDA, LAD/DIAG, LCX/OM. Since we started this tech-
nique we have no target vessel re-vasularization in those
36 patiens.
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Conclusion: The vast majority of our patients are
diabetic and this technique could resolve the PCI limita-
tions in those patients even after DES implantation.
http://dx.doi:10.1016/j.jsha.2012.06.246
Predicting occult paroxysmal atrial fibrillation
(AF) in transient ischemic attack (TIA) or strokes
Chandni Sharma, Mrinal Sharma
Relevance: AF accounts for 75,000 cases of strokes
per year, yet 40% of strokes may have no apparent etiol-
ogy. Etiology of these strokes may be occult PAF. The lab-
oratory and echocardiography markers may help identify
those at risk of PAF.
Purpose: Paroxysmal AF (PAF) is a significant risk
factor for TIA/stroke. However, routine Holters/ECG
often fail to detect PAF. Our aim was to evaluate labora-
tory and echocardiographic parameters to predict PAF.
Participants: 428 patients were enrolled, 220 males
and 208 females, 51% and 49%, respectively, a mean
age of 72.3 years. PAF present group 68 patients (16%)
versus PAF absent group 360 patients (84%).
Method: The 24 h-Holters recorded for evaluation of
TIA/strokes were analyzed for PAF. Patients were
divided into PAF present or absent groups.
Analysis: Multivariate regression analysis was used
to investigate BNP (Brain Natriuretic Peptide), D-dimer,
mitral regurgitation (MR), left atrial size (LA), left ventric-
ular hypertrophy (LVH) and diastolic dysfunction.
Results: BNP, MR, LA size, LVH, diastolic dysfunc-
tion were significantly higher in patients showing PAF
on their Holters than those without PAF. Multivariate
logistic regression analysis demonstrated BNP 400 pg/
ml (OR, 14.8; 95% CI 6.5–45, P < 0.01), MR (OR, 8.1; 95%
CI 3.12–26.2, P < 0.001), LA size 4.0 cm (OR, 5.2; 95% CI
2.01–14.6, P < 0.002), LVH 1.2 cm (OR, 4.9; 95% CI 1.2–
6.88, P < 0.001), diastolic dysfunction (OR, 6.7; 95% CI
2.3–27.2, P < 0.021).
Conclusion: Patients with cryptogenic TIA and asso-
ciated elevated BNP, LVH, MR, enlarged LA, and dia-
stolic dysfunction may have PAF as an etiology.
http://dx.doi:10.1016/j.jsha.2012.06.247
Clinical presentation and short term outcome of
acute coronary syndromes in native young saudi
population
Mushabab A. Al-Murayeh, Adel A. Al-Masswary,
Mohamed D. Dardir, Mohamed S. Moselhy, Ali A.
Youssef
Background: Literature about acute coronary syn-
dromes (ACS) in young population in the Middle East
is scarce. Moreover, such data in native young Saudi Ara-
bians is lacking.
Methods: We retrospectively reviewed our data base
between January 2006 and May 2009, 924 patients were
diagnosed to have ACS. Among them 107 patients
(11.6%) met our definition of young [66 (61.7%) male 6 45
years, and 41 (38.3%) female 6 55 years].
Results: The overall age was 42:3 7:9 years. Diabe-
tes mellitus prevalence was 36.4% in males and 63.4% in
females, while 30.0% of males and 34.1% of females had
hypertension. Active smoking was reported in 40.9% of
the males but none of the females. A body mass
indexP 25 was found in 30.3% of males and 34.1% of
females. Overall 21.5% of the patients had dyslipidemia.
Past history of coronary artery disease was documented
in 18 patients (16.8%). The discharge diagnoses were
ST-segment elevation myocardial infarction in 41
(38.3%) patients, non-ST-segment elevation MI in 36
patients (33.6%) and unstable angina in 30 (28.0%)
patients. Coronary angiography was performed in 86
patients (80.4%), among them 42 patients (48.8%) had sin-
gle vessel and 24 patients (27.9%) hadP 2 vessel disease.
One patient had in-hospital acute ischemic stroke and
more women (29.3%) were discharged with clinical diag-
nosis of heart failure.
Conclusions: Several common cardiovascular risk
factors have alarming incidences in native young Saudi
adults presented with ACS. This finding necessitates an
aggressive approach for population based intervention.
http://dx.doi:10.1016/j.jsha.2012.06.248
Comparison of echocardiography and CT angiog-
raphy for measurement of aortic annulus diame-
ters before transcatheter aortic valve implantation
Nada Alshayeb, Ahmed Alsaileek, Ahmad Omran
Objectives: Accurate assessment of the aortic annu-
lus diameter is crucial for successful transcather aortic
valve implantation (TAVI). We compared the aortic
annulus diameter obtained by echocardiography and
computed tomography (CT) angiography in patients
referred for TAVI.
Methods: On echo, the aortic annulus diameter was
measured from parasternal long axis view in systole. An
average of two measurements was calculated. On CT, the
annulus was measured in cross-sectional view (perpen-
dicular to the flow axis). Three diameters were obtained;
maximum (Dmax), minimum (Dmin) and the mean
(Dmean) (from cross-sectional area (CSA)) diameters
(Fig. 1). The echo and CT measurements were performed
independently. The degree of agreement was assessed by
Bland-Altman plot.
Results: Twenty-eight patients (mean age 76 ± 8
years, males were 21) with severe symptomatic aortic ste-
nosis comprised the study population. The aortic annulus
diameters were 22 ± 1.4 mm on echo and 26.6 ± 2.8 mm,
20.4 ± 1.9 mm and 23.5 ± 1.9 mm on CT Dmax, Dmin and
Dmean, respectively. Regardless of the CT method, there
was good agreement between the echo and CT measure
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